Symbols

ONCY

Oncolytics Biotech·NASDAQ

--(--)

5.04 / 10

Netural

Analyst coverage is thin: one Strong‑Buy from HC Wainwright, yielding a neutral sentiment score (5.04). Fund‑flow is good (7.32/10) but all size‑segments show negative trends despite modest inflow ratios (~0.47). Overall, capital interest is positive while analyst confidence is limited.

Fund Flow Rating

Analyst RatingStrong Buy

Wall Street Opinions

Strong Buy

100%

Buy

Hold

Sell

Strong Sell

Date2025-11-17

InstitutionHC Wainwright & Co.

Times predicted1

Historical Win Rate0.0%

What is the market sentiment for ONCY?

ONCY holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.04/10 (Netural).